首页> 外文OA文献 >Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.
【2h】

Evaluation of diagnostic strategies for bladder cancer using computed tomography (CT) urography, flexible cystoscopy and voided urine cytology: results for 778 patients from a hospital haematuria clinic.

机译:使用计算机断层扫描(CT)尿路造影,柔性膀胱镜检查和尿液细胞学检查评估膀胱癌的诊断策略:来自医院血尿诊所的778例患者的结果。

摘要

UNLABELLED: Study Type - Diagnostic (exploratory cohort) Level of Evidence 2b What's known on the subject? and What does the study add? Haematuria clinics with same day imaging and flexible cystoscopy are an efficient way for investigating patients with haematuria. The principal role of haematuria clinics with reference to bladder cancer is to determine which patients are 'normal' and may be discharged, and which patients are abnormal and should undergo rigid cystoscopy. It is well recognised that CT urography offers a thorough evaluation of the upper urinary tract for stones, renal masses and urothelial neoplasms but the role of CT urography for diagnosing bladder cancer is less certain. The aim of the present study was to evaluate the diagnostic accuracy of CT urography in patients with visible haematuria aged >40 years and to determine if CT urography has a role for diagnosing bladder cancer. This study shows that the optimum diagnostic strategy for investigating patients with visible haematuria aged >40 years with infection excluded is a combined strategy using CT urography and flexible cystoscopy. Patients positive for bladder cancer on CT urography should be referred directly for rigid cystoscopy and so avoid flexible cystoscopy. The number of flexible cystoscopies required therefore may be reduced by 17%. The present study also shows that the diagnostic accuracy of voided urine cytology is too low to justify its continuing use in a haematuria clinic using CT urography and flexible cystoscopy. OBJECTIVES: To evaluate and compare the diagnostic accuracy of computed tomography (CT) urography with flexible cystoscopy and voided urine cytology for diagnosing bladder cancer. To evaluate diagnostic strategies using CT urography as: (i) an additional test or (ii) a replacement test or (iii) a triage test for diagnosing bladder cancer in patients referred to a hospital haematuria rapid diagnosis clinic. PATIENTS AND METHODS: The clinical cohort consisted of a consecutive series of 778 patients referred to a hospital haematuria rapid diagnosis clinic from 1 March 2004 to 17 December 2007. Criteria for referral were at least one episode of macroscopic haematuria, age >40 years and urinary tract infection excluded. Of the 778 patients, there were 747 with technically adequate CT urography and flexible cystoscopy examinations for analysis. On the same day, patients underwent examination by a clinical nurse specialist followed by voided urine cytology, CT urography and flexible cystoscopy. Voided urine cytology was scored using a 5-point system. CT urography was reported immediately by a uroradiologist and flexible cystoscopy performed by a urologist. Both examinations were scored using a 3-point system: 1, normal; 2, equivocal; and 3, positive for bladder cancer. The reference standard consisted of review of the hospital imaging and histopathology databases in December 2009 for all patients and reports from the medical notes for those referred for rigid cystoscopy. Follow-up was for 21-66 months. RESULTS: The prevalence of bladder cancer in the clinical cohort was 20% (156/778). For the diagnostic strategy using CT urography as an additional test for diagnosing bladder cancer, when scores of 1 were classified as negative and scores of 2 and 3 as positive, sensitivity was 1.0 (95% confidence interval [CI] 0.98-1.00), specificity was 0.94 (95% CI 0.91-0.95), the positive predictive value (PPV) was 0.80 (95% CI 0.73-0.85) and the negative predictive value (NPV) was 1.0 (95% CI 0.99-1.00). For the diagnostic strategy using CT urography as a replacement test for flexible cystoscopy for diagnosing bladder cancer, when scores of 1 were classified as negative and scores of 2 and 3 as positive, sensitivity was 0.95 (95% CI 0.90-0.97), specificity was 0.83 (95% CI 0.80-0.86), the PPV was 0.58 (95% CI 0.52-0.64), and the NPV was 0.98 (95% CI 0.97-0.99). Similarly using flexible cystoscopy for diagnosing bladder cancer, if scores of 1 were classified as negative and scores of 2 and 3 as positive, sensitivity was 0.98 (95% CI 0.94- 0.99), specificity was 0.94 (95% CI 0.92-0.96), the PPV was 0.80 (95% CI 0.73-0.85) and the NPV was 0.99 (95% CI 0.99-1.0). For the diagnostic strategy using CT urography and flexible cystoscopy as a triage test for rigid cystoscopy and follow-up (option 1), patients with a positive CT urography score are referred directly for rigid cystoscopy, and patients with an equivocal or normal score were referred for flexible cystoscopy. Sensitivity was 1.0 (95% CI 0.98-1.0), specificity was 0.94 (95% CI 0.91-0.95), the PPV was 0.80 (95% CI 0.73-0.85), and the NPV was 1.0 (95% CI 0.99-1.0). For the diagnostic strategy using CT urography and flexible cystoscopy as a triage test for rigid cystoscopy and follow-up (option 2), patients with a positive CT urography score are referred directly for rigid cystoscopy, patients with an equivocal score are referred for flexible cystoscopy and patients with a normal score undergo clinical follow-up. Sensitivity was 0.95 (95% CI 0.90-0.97), specificity was 0.98 (95% CI 0.97-0.99), the PPV was 0.93 (95% CI 0.87-0.96), and the NPV was 0.99 (95% CI 0.97-0.99). For voided urine cytology, if scores of 0-3 were classified as negative and 4-5 as positive for bladder cancer, sensitivity was 0.38 (95% CI 0.31-0.45), specificity was 0.98 (95% CI 0.97-0.99), the PPV was 0.82 (95% CI 0.72-0.88) and the NPV was 0.84 (95% CI 0.81-0.87). CONCLUSIONS: There is a clear advantage for the diagnostic strategy using CT urography and flexible cystoscopy as a triage test for rigid cystoscopy and follow-up (option 1), in which patients with a positive CT urography score for bladder cancer are directly referred for rigid cystoscopy, but all other patients undergo flexible cystoscopy. Diagnostic accuracy is the same as for the additional test strategy with the advantage of a 17% reduction of the number of flexible cystoscopies performed. The sensitivity of voided urine cytology is too low to justify its continuing use in a hospital haematuria rapid diagnosis clinic using CT urography and flexible cystoscopy.
机译:未贴标签:研究类型-诊断(探索性队列)证据等级2b关于该主题的已知信息?这项研究增加了什么?带有当天成像和柔性膀胱镜检查的血尿诊所是调查血尿患者的有效方法。血尿诊所针对膀胱癌的主要作用是确定哪些患者“正常”且可以出院,哪些患者异常并应进行硬性膀胱镜检查。众所周知,CT尿路造影可以彻底评估上尿路的结石,肾脏肿块和尿路上皮肿瘤,但CT尿路造影在诊断膀胱癌中的作用尚不确定。本研究的目的是评估CT尿路造影对40岁以上可见血尿患者的诊断准确性,并确定CT尿路造影是否对膀胱癌具有诊断作用。这项研究表明,调查年龄在40岁以上但不包括感染的可见血尿患者的最佳诊断策略是结合使用CT尿路造影和柔性膀胱镜检查的策略。 CT泌尿系造影对膀胱癌阳性的患者应直接接受硬性膀胱镜检查,因此应避免进行柔性膀胱镜检查。因此,所需的柔性膀胱镜检查的数量可以减少17%。本研究还表明,尿尿细胞学检查的诊断准确性太低,无法证明其在使用CT尿路造影和柔性膀胱镜检查的血尿诊所中继续使用是合理的。目的:评估和比较计算机断层扫描(CT)尿路造影与柔性膀胱镜检查和尿液细胞学检查对膀胱癌的诊断准确性。使用CT尿路造影评估诊断策略的方法如下:(i)附加检查或(ii)替代检查或(iii)分诊检查,以诊断转诊至医院血尿快速诊断诊所的患者的膀胱癌。患者与方法:该临床队列由2004年3月1日至2007年12月17日转诊至医院血尿快速诊断诊所的连续778例患者组成。转诊的标准为至少一次发作性肉眼血尿,年龄> 40岁且尿频排除道感染。在778例患者中,有747例接受了技术上足够的CT尿路造影和柔性膀胱镜检查以进行分析。当天,患者由临床护士专家进行了检查,随后尿细胞学检查无效,CT尿路造影和软性膀胱镜检查。无效尿细胞学评分采用5分制。泌尿外科医师立即报告了CT尿路造影,泌尿科医师进行了柔性膀胱镜检查。两项检查均使用3分制进行评分:1,正常; 2,模棱两可; 3,膀胱癌阳性。参考标准包括2009年12月对所有患者的医院影像学和组织病理学数据库的回顾,以及刚进行膀胱镜检查的患者的医学注释报告。随访时间为21-66个月。结果:临床队列中膀胱癌的患病率为20%(156/778)。对于使用CT尿路造影作为诊断膀胱癌的附加测试的诊断策略,当将1分定为阴性,将2分和3分定为阳性时,敏感性为1.0(95%置信区间[CI] 0.98-1.00),特异性为0.94(95%CI 0.91-0.95),阳性预测值(PPV)为0.80(95%CI 0.73-0.85),阴性预测值(NPV)为1.0(95%CI 0.99-1.00)。对于使用CT尿路造影术作为用于膀胱癌诊断的柔性膀胱镜检查的替代测试的诊断策略,当将1分定为阴性,将2分和3分定为阳性时,敏感性为0.95(95%CI 0.90-0.97),特异性为0.83(95%CI 0.80-0.86),PPV为0.58(95%CI 0.52-0.64)和NPV为0.98(95%CI 0.97-0.99)。同样地,使用软性膀胱镜检查诊断膀胱癌时,如果将1分为阴性,将2和3分为阳性,则敏感性为0.98(95%CI 0.94- 0.99),特异性为0.94(95%CI 0.92-0.96), PPV为0.80(95%CI 0.73-0.85),NPV为0.99(95%CI 0.99-1.0)。对于使用CT尿路造影和柔性膀胱镜检查作为硬性膀胱镜检查和随访的分类测试的诊断策略(选项1),将CT尿路造影评分阳性的患者直接转诊进行硬性膀胱镜检查,并且对模棱两可或正常评分的患者进行转诊用于柔性膀胱镜检查。敏感性为1.0(95%CI 0.98-1.0),特异性为0.94(95%CI 0.91-0.95),PPV为0.80(95%CI 0.73-0.85),NPV为1.0(95%CI 0.99-1.0) 。对于使用CT尿路造影和柔性膀胱镜检查作为硬性膀胱镜检查和随访的分类测试的诊断策略(选项2),CT尿路造影评分阳性的患者可直接转诊进行硬性膀胱镜检查,得分不确定的患者将接受软膀胱镜检查,得分正常的患者将接受临床随访。敏感性为0.95(95%CI 0.97-0.99),特异性为0.98(95%CI 0.97-0.99),PPV为0.93(95%CI 0.87-0.96),NPV为0.99(95%CI 0.97-0.99) 。对于无效的尿液细胞学检查,如果膀胱癌的0-3评分为阴性,而4-5评分为阳性,则敏感性为0.38(95%CI 0.31-0.45),特异性为0.98(95%CI 0.97-0.99), PPV为0.82(95%CI 0.72-0.88),NPV为0.84(95%CI 0.81-0.87)。结论:CT尿路造影和柔性膀胱镜检查作为硬性膀胱镜检查和随访的分类试验的诊断策略具有明显优势(选择1),其中膀胱癌CT尿路造影评分阳性的患者可直接转诊为刚性膀胱镜检查,但所有其他患者均接受了柔性膀胱镜检查。诊断准确度与其他测试策略相同,其优点是执行的柔性膀胱镜检查次数减少了17%。尿液尿液细胞学检查的敏感性太低,无法证明其在使用CT尿路造影和柔性膀胱镜检查的医院血尿快速诊断诊所中继续使用是合理的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号